Company news

Amgen Inc. news in 2023

Amgen Inc.'s news releases, calls and decks from 2023, newest first.

View company

AMJEVITA™ (adalimumab-atto), first biosimilar to Humira®, now available in the united states

January 30, 2023

Amgen reports fourth quarter and full year 2022 financial results

January 30, 2023

Amgen posts full transcript and audio replay of fourth quarter and full year 2022 earnings webcast

January 30, 2023

Amgen announces webcast of 2022 fourth quarter and full year financial results

January 25, 2023

Amgen and BioLabs LA at The Lundquist Institute announce Nammi Therapeutics to receive the third Amgen Golden Ticket

January 5, 2023

Amgen to present at the 41st annual j.p. morgan healthcare conference

January 3, 2023

← Newer news releases

Calls in 2023

Decks in 2023